PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology
NCT01387711
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Actinic Keratosis
Interventions
DRUG:
PEP005 (Ingenol mebutat Gel, 0.05 %)
Sponsor
LEO Pharma